Relief from pain, swelling

and immune-related disease.

Novel Patented Anti-Inflammatory Engineered-Curcumin Supplement!

Relief from pain, swelling and other common ailments associated with systemic inflammation. Patented pharmacology delivered by a novel research-supported mechanism that is recently peer-reviewed and published.


Curcumin extracts typically deliver a curcuminoid proportion as: diferuloylmethane (curcumin I) 75–80%; demethoxycurcumin (DMC — curcumin II) 9-12%; and bisdemethoxycurcumin (BDMC — curcumin III) 0.2–3%. Regular curcumin extracts (even the 95% variation) maximally delivers 3% of this BDMC activity and therefore cannot inhibit a key protein (MSK1) that regulates inflammatory cytokine transcription (generation).


The patented Curcumin BDMC30™ is engineered to deliver a minimum 30% concentration of these MSK1-inhibiting curcuminoids; while the professional series (ND series) variation, Curcumin BDMC50™ delivers a minimum 50% concentration.



  • Helps Relieve Chronic Inflammation

  • Relieves Joint Pain

  • Inhibits two key regulator proteins (NF-kB & MSK1) in the inflammatory pathway

  • (Regular curcumin 95% can only inhibit one of these (NF-kB))

  • Supports Immune System Efficiency

  • COX- 2 Inhibitor

  • Helps Support Anti-Aging

  • Helps Preserve Healthy Bones & Joints

  • Works faster (in hours) instead of days (like regular curcumin 95% does)


Provides antioxidants for the maintenance of good health. Used in herbal medicine to help relieve joint inflammation.


Adults: 1-3 Capsules daily.


Cautions and warnings: Consult a health care practitioner prior to use if you are pregnant or breastfeeding, if taking antiplatelet medication or blood thinners; if suffering from bile duct obstruction such as gallstones; if you have stomach ulcers or excess stomach acid; or if symptoms persist or worsen. Do not use if seal on cap is broken or missing.

Research Details


Curcumin BioBDMC inhibits a second key protein (MSK1) involved in activating inflammation.

Regular Curcumin of many types tested and displayed in the same graph cannot inhibit (stop) this protein (MSK1).


Ultimately:  Curcumin BioBDMC inhibits two key proteins (MSK1 and NF-kB) while regular curcumin 95% only inhibits one of these (NF-kB) as is commonly known to be its anti-inflammatory mechanism.

Physical RESULT of this additive Curcumin BioBDMC pharmacology: 

  •   Faster acting – in hours instead of days

  •  Works for more difficult cases

curcuminbiobdmc graphs.png

Clearing the Path to Potent Longevity


Attain Healthy Essential Fatty Acid Status and Healthy Inflammatory Activity.




Curcumin displays strong anti-inflammatory potential in the entire body, and in the near future it will be recognized as one of the vital anti-aging nutrients. It plays a core role in any health program. I’ve been using extremely high doses of curcumin (turmeric 95% curcuminoids) for various reasons, which you’ll see disclosed throughout this book series.


Curcuminoids, extracted from turmeric, contribute a potent defense of DNA. Studies have compared its anti-inflammatory potential and

anti-cancer properties against common pharmaceutical therapies to reveal, in some cases, better results and in other cases conclusive synergistic value. Have pharmaceutical companies reported on this? No, they haven’t. The incredible facts rising out of this research reveal that curcumin, unlike a common nonsteroidal anti-inflammatory drug (NSAID), doesn’t induce gastrointestinal, liver, and/or kidney toxicity.


Having read reports of the potential of curcuminoids to down-regulate

cyclo-oxygenase-enzyme activity and eicosanoid-hormone biosynthesis, I was confident some time ago that they regulated gene expression of the enzymes involved in eicosanoid-hormone production, much like the protective NF-kappa-B gene influence of alpha lipoic acid. In this way curcuminoids prevent the overexpression of genes involved in the immune and inflammatory response.


After ongoing, relentless search, I found my answer. Curcumin had

been investigated for its ability to suppress the activation of HIV to the status of AIDS. In a 1993 Harvard University study it was demonstrated that curcumin inhibited the expression of a gene in the DNA of the virus. This gene was responsible for turning on HIV to initiate the assault on the body. Recently, through this historical work, curcumin has been shown to block the activation of NF-kappa-B. Not only is curcumin a powerful HIV inhibitor, it can be justifiably applied as part of the anti-aging and anti-inflammatory program with scientific proof that it works powerfully alongside or independent of alpha lipoic acid.  This insight, was the impetus for my push to study curcuminoids exclusively and define with more accuracy how they can be used and even engineered to increase their potential to bring general health benefits and disease treatment.

Attain Healthy Essential Fatty Acid

Status &
Inflammatory Activity

Screen Shot 2021-06-08 at 1.39.19 PM.png

Related Articles